Medical Weight Loss for Chicago, Illinois Residents
Chicago, Illinois residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Chicago through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Chicago Residents Choose New Hope Weight Loss
New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, California that has treated over 5,400 patients since 2020. We serve Chicago, Illinois through telehealth at some of the most transparent prices anywhere, semaglutide from $166/month and tirzepatide from $233/month · just $7.70/day. No insurance battles, no hidden fees. Care is overseen by Dr. Anjmun Sharma, M.D.
Chicago is served through telehealth from our Costa Mesa, California clinic. The physician consultation, prescription, and follow-up all happen by secure video, with compounded medication shipped to your Chicago address.
Patients across Chicago and the surrounding area connect with Dr. Sharma by secure video, wherever they live in Illinois. We care for patients throughout the Loop, Lincoln Park, Wicker Park, Hyde Park, Lakeview, and the greater Chicagoland area. There is no distance surcharge for Chicago patients, and HSA, FSA, Klarna, and Affirm are all accepted.
Telehealth removes the distance between Chicago and specialized care: your consultation happens wherever you are in Illinois. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you before you begin.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Chicago patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Chicago
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Chicago address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Chicago
Does New Hope Weight Loss treat patients in Chicago?
Yes. Although the clinic is in Costa Mesa, California, we treat Chicago, Illinois residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Chicago?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Chicago address in cold-pack packaging.
What do Chicago patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Chicago do you serve?
We serve patients from across Chicago by telehealth, including the Loop, Lincoln Park, Wicker Park, Hyde Park, Lakeview, and the greater Chicagoland area.
Can Chicago patients do every visit by video?
Yes. Every part of the program is by video for Chicago patients, the initial consultation with Dr. Sharma, dose check-ins during the 90 days, and ongoing follow-up. Compounded medication ships to your Chicago address; there is no need to travel.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Chicago, Illinois by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.